The hydrogen bond occurred between the Tetrakis (4-aminopyridine-kN1) di chloride copper (II) monohydrate and Human Serine Racemase and Sphingosine 1-phosphate (S1P) lyase identified using molecular docking tool (Auto dock tools) to understand the drug-drug interaction. Based on the crystallographic structure of Tetrakis (4-aminopyridine-kN1) di chloride copper (II) monohydrate with enzyme and protein obtained using Auto dock tools and analysis through hirshfeld surface show that the Hydrogen bonding interaction is restricted by N-H…O hydrogen bonding and both the molecular structure show the antibiotic sensitivity with these microorganisms. These studies identify the possibilities of Tetrakis (4-aminopyridine-kN1) di chloride copper (II) monohydrate to act as drug with required changes in its molecular structure. These analysis are recently application of inhibitory action of therapeutic target for treatment of Multiple Sceloris(MS). 4-Aminopyridine metal complex increase neurological effects in pottasium(K+) channel blockade. In the field of antineoplastic drug development the transition metals are dynamic in electron affinity, reactivity and geometry . For the drug chemist the usage of transition metals act as a effective tool to develop and study molecules -drug interactions.
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